Study details
Enrolling now
A Randomized, Double Blind, Placebo Controlled Clinical Trial to Examine the Benefits of an Oral Product in Women With Menopausal Symptoms Including Vasomotor Symptoms (VMS)
Olly, PBC
NCT IDNCT07033013ClinicalTrials.gov data as of Apr 2026
Target enrollment
40
Study length
about 25 days
Ages
40–65
Sex
Female only
Locations
1 site in CA
About this study
This trial is testing a dietary supplement for women experiencing menopausal symptoms like hot flashes. Participants will take either the supplement or a placebo daily for 25 days while tracking their symptoms using diaries and questionnaires. The goal is to see if the supplement helps reduce these symptoms.
Based on ClinicalTrials.gov records.
What participants do
- 1.Dietary Supplement with actives
- 2.Placebo
DrugDietary Supplement
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
dietary supplement
Endpoints
Secondary: Improvement of overall daily menopausal vasomotor symptoms